MAPK-IN-1 (Compound 2) is a MAPK signaling pathway inhibitor. MAPK-IN-1 exhibits AChE inhibitory activity with an IC50 of 23.84 µM. MAPK-IN-1 shows anti-neuroinflammatory and neuroprotective activity and can be used for Alzheimers disease research[1].